9
Sep
2024
Candid Therapeutics Emerges with $370M to Develop T-Cell Engagers for Autoimmunity
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
9
Sep
2024
The Enchantments Traverse: A Photo Gallery
The 4th annual Timmerman Traverse for Life Science Cares wrapped up last month, but I’m feeling a bit remiss for not telling the whole story. This year’s successful $1 million campaign came in two parts. First, there were a pair of back-to-back day hikes in the North Cascades with a team composed mostly of newcomers to the Life Science Cares... Read More